Title : Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors.

Pub. Date : 2014 Jun

PMID : 26158148






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND/AIMS: Sorafenib, a drug that inhibits Raf serine/threonine kinases mediating cell proliferation and receptor tyrosine kinases involved in angiogenesis, is approved for treatment of advanced hepatocellular carcinoma. Sorafenib zinc fingers and homeoboxes 2 Homo sapiens